Details of the Drug

General Information of Drug (ID: DMYIIDP)

Drug Name
MC-1101
Indication
Disease Entry ICD 11 Status REF
Diabetic retinopathy 9B71.0 Phase 2/3 [1]
Cross-matching ID
PubChem CID
9351
TTD ID
D01WLE
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT02127463) Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration. U.S. National Institutes of Health.